According to FutureWise analysis the market for phytopathological disease diagnostics in 2023 is US$ 101.38 million, and is expected to reach US$ 144.39 million by 2031 at a CAGR of 4.50%.
Increase in the prevalence of phtopathological diseases, growing developments in the diagnostic technologies for treating these diseases are some factors driving the phytopathological disease diagnostics market growth. The plant pathology sector has made some substantial developments by elucidating the principles of disease epidemics and this has resulted in improvements in the empirical understanding of disease dynamics. Furthermore, it has improved the accuracy of a disease outbreak or the necessity for real-time disease control and strategic solutions to disease-related issues.
Molecular diagnostic methods based on PCR are being increasingly used for guiding the diagnosis of phytopathological diseases. Furthermore, rising prevalence of plant-related diseases along with the risen availability of genomic and genetic information, which has resulted in the rapid PCR incorporation in clinical laboratories. The high sensitivity, specificity and low requirement of samples has made molecular assays a regularised method for detecting pathogens during a disease outbreak. Such phytopathological disease diagnostics market trends shall propel the market growth.